Method for preparing tigecycline intermediate and salt thereof

A technology for tigecycline and intermediates, which is applied in the field of organic synthesis of drugs, can solve the problems of large impurity content of the 4-position epimer, many impurities, and high cost, and achieve easy-to-obtain raw materials, simple equipment requirements, and easy operation Effect

Inactive Publication Date: 2011-01-26
ZHEJIANG UNIV
View PDF9 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The first method not only has a lower yield (50-60%), but also has more impurities, especially the 4-position epimer impurity content caused by the reaction is relatively large
Although the second method has a yield of 90% in this step of chloroacetylation, the yield of reacting with tert-butylamine is also low (50%), and the route is relatively long simultaneously
This also makes the above-mentioned three synthetic routes of tigecycline subject to the restriction of raw material minocycline, and the cost is higher

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing tigecycline intermediate and salt thereof
  • Method for preparing tigecycline intermediate and salt thereof
  • Method for preparing tigecycline intermediate and salt thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 19

Embodiment 29

Embodiment 39

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a method for preparing a tigecycline intermediate shown as a formula (1) and a salt thereof, which comprises the preparation route shown in the specifications. The preparation route has the advantages of cheap and readily available raw materials, avoidance of an ortho-position and para-position mixture during nitration, high yield in each step of reaction, no need of a minocycline intermediate, simple and convenient operation and simple equipment requirement, and is a synthesis process for industrially producing tigecycline.

Description

technical field The invention relates to the field of organic synthesis of medicines, in particular to a process for synthesizing tigecycline intermediates and salts thereof. Background technique The chemical name of Tigecycline is [4S-(4α,12aα)]-4,7-bis(dimethylamino)-9-[(tert-butylamino)acetamido]-1,4,4a , 5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-tetracenecarboxamide, its structural formula is as follows: (10) Tigecycline Tigecycline is the first marketed variety of a new class of antibiotics—glycylcycline (glycylcycline), which is mainly used to treat infections caused by Gram-negative and positive pathogenic bacteria, anaerobic bacteria, and methicillin-resistant grapevine aureus. Complicated intra-abdominal infection, skin and skin tissue infection (cSSSI), pneumococcal infection, etc. This product was successfully developed by Wyeth, and was approved for marketing in the United States for the first time in July 2005. Clinical medical resear...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07C237/26C07C231/12
Inventor 杨健余长泉
Owner ZHEJIANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products